Related Experiment Video
Updated: May 17, 2026

09:09
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
Fluorescent mu selective opioid ligands from a mixture based cyclic peptide library.
Yangmei Li1, Colette T Dooley, Jaime A Misler
1Torrey Pines Institute for Molecular Studies, Port Saint Lucie, Florida 34987, United States.
ACS Combinatorial Science
|November 1, 2012
Summary
Researchers developed a cyclic peptide library to find new mu opioid receptor ligands. Two high-affinity cyclic peptides were identified, with one isomer showing a 14 nM binding affinity, demonstrating selectivity for the mu-opioid receptor.
Area of Science:
- Medicinal Chemistry
- Peptide Chemistry
- Neuroscience
Background:
- Cyclic peptides are valuable scaffolds for drug discovery due to their conformational rigidity and metabolic stability.
- The mu opioid receptor is a key target for pain management, but current therapeutics have limitations.
Purpose of the Study:
- To generate and screen a positional scanning cyclic peptide library to identify novel ligands for the mu opioid receptor.
- To synthesize and characterize high-affinity cyclic peptides targeting the mu opioid receptor.
Main Methods:
- A positional scanning cyclic peptide library was synthesized using a thioester scaffold, incorporating diverse L- and D-amino acids at variable positions.
- The library was screened using a binding assay against the mu opioid receptor.
- Hit compounds were further synthesized and characterized, including isomer analysis.
Main Results:
- Screening identified active amino acid combinations for mu opioid receptor binding.
- Two cyclic peptides demonstrated high binding affinities.
- The most potent cyclic peptide showed a side chain-to-tail isomer with a binding affinity of 14 nM, outperforming its head-to-tail isomer (39 nM).
- Both identified isomers exhibited selectivity for the mu-opioid receptor.
Conclusions:
- Positional scanning is an effective strategy for identifying potent cyclic peptide ligands.
- Novel cyclic peptides with high affinity and selectivity for the mu opioid receptor were discovered.
- The findings provide a basis for developing new analgesics with improved profiles.

